|
|
|
| Clinical efficacy of Butylphthalide combined with Sodium Ozagrel in treating acute severe cerebral infarction |
| WANG Yanru ZHOU Guoliang▲ ZHANG Yuechan BAI Fengying SONG Guijü |
| The Second Medical Department, Jizhou District Hospital, Hengshui City, Hebei Province, Hengshui 053200, China |
|
|
|
Abstract Objective To investigate the clinical efficacy of Butylphthalide combined with Sodium Ozagrel in the treatment of acute severe cerebral infarction. Methods In this study, 204 patients with acute severe cerebral infarction treated in the Jizhou District Hospital from January 2014 to January 2016 were analyzed retrospectively. They were divided into observation group (120 cases) and control group (84 cases) according to clinical treatment methods. Patients in the control group were treated with basic treatment combined with Sodium Ozagrel, while patients in the observation group were treated with Butylphthalide based on the control group. They were treated for 1 week. The serum cholinesterase (CHE), interleukin-6 (IL-6) and the rate of ECG change before and after treatment were observed. The national institutes of health (NIHSS) score and Glasgow coma (GCS) were wsed to compare the clinical efficacy of the two groups. Results After treatment, the GCS scores and CHE levels were increased (P < 0.05), NIHSS scores and the IL-6 levels were decreased (P < 0.05), while the improvement of the observation group was more remarkable than control group (P < 0.05). Besides, the rate of abnormal ECG change was lower than that of the control group (P < 0.05). Conclusion The combination of Butyphthalide and Sodium Ozagrel in treating acute severe cerebral infarction can effectively increase the serum cholinesterase level, down-regulate the level of IL-6, reduce the incidence of ECG abnormalities and improve the curative effect of neurological deficits.
|
|
|
|
|
|
[1] 李春瑶，司味鑫，赵越，等.血清胆碱酯酶水平与急性脑梗死病情严重程度及预后的相关性[J].中国医科大学学报，2016，45（5）：417-421.
[2] 丁玉林，马小虎，冶明星.100例急性脑梗死心电图改变的临床分析[J].四川医学，2013（12）：1935-1936.
[3] 吴娟，陈永.丁苯酞对急性脑梗死的临床疗效及血液流变学的影响[J].重庆医学，2012，41（33）：3488-3489.
[4] 刘永刚，许云鹤，赵小妹，等.丁苯酞联合奥扎格雷钠治疗急性脑梗死的临床研究[J].中华高血压杂志，2014，22（2）：79-80.
[5] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国全科医学，2011，14（12）：4013-4017.
[6] 中华医学会神经病学分会.中国重症脑血管病管理共识2015[J].中华神经科杂志，2016，49（3）：192-195.
[7] Kim SH，Lee JY，Park SH，et al. Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volume [J]. Int J Med Sci，2013，10（1）：103.
[8] 耿直，丁霞，沈洁.重症脑梗死患者急性期心肌标志物和心电图的改变与预后的关系[J].河北医学，2010，16（6）：646-648.
[9] Vedel AG，Holmgaard F，Rasmussen LS，et al. Perfusion Pressure Cerebral Infarct（PPCI）trial-the importance of mean arterial pressure during cardiopulmonary bypass to prevent cerebral complications after cardiac surgery：study protocol for a randomised controlled trial [J]. Trials，2016，17（1）：1-11.
[10] Nakaguchi H，Matsuno A，Okubo T，et al. Relationship between silent brain infarction and amount of daily coffee consumption in middle age [J]. J Stroke Cerebrovas Dis，2016，25（7）：1678-1682.
[11] Kato Y，Hayashi T，Uchino A，et al. Fusiform dilatation of the outer contour of a dissected anterior cerebral artery revealed by magnetic resonance cisternography in a patient with simultaneous cerebral infarction and subarachnoid hemorrhage [J]. J Stroke Cerebrovasc Dis，2014，23（6）：1717-1720.
[12] 刘进，王磊.胆碱酯酶对判断全身炎症反应综合征患者预后的价值[J].临床荟萃，2012，27（1）：48-50.
[13] 颜玮茹，廖春梅.重症脑梗死患者白细胞介素-18与预后的相关性[J].中国老年学杂志，2016，36（11）：5562-5564.
[14] 黄日忠.血浆IL-18浓度与脑梗死预后相关性[J].放射免疫学杂志，2013，26（3）：317-319.
[15] 李洋阳，吴卫娟，孟然.脑梗死并发脑心综合征的研究进展[J].中华临床医师杂志：电子版，2017，11（1）：91-94.
[16] 李宏治，张宝成，钟志越.脑心综合征患者的心电图及心肌损伤标志物的变化[J].中国心脏起搏与心电生理杂志，2011，25（5）：416-417.
[17] 李陈，刘敏，王振宇，等.急性脑卒中患者发生脑心综合征的相关分析及其预后研究[J].重庆医学，2014，43（14）：1732-1735.
[18] 施惠敏.丁苯酞对急性脑梗死患者血清白介素-6的影响[D].兰州：兰州大学，2013.
[19] 赵帅，韩冰，孟祥伟.大剂量阿司匹林肠溶片联合奥扎格雷钠治疗急性脑梗死的临床疗效与安全性[J].中国社区医师：医学专业，2012，14（17）：132-133.
[20] 黄寿新，徐招柱.SpO2、GCS评分和血清乙酰胆碱酯酶与急性有机磷中毒病情和预后的关系分析[J].岭南急诊医学杂志，2016，1（2）：88-91.
[21] 曹捷.丁苯酞注射液联合奥扎格雷钠治疗急性脑梗死68例效果观察[J].宁夏医学杂志，2013，35（6）：535-536. |
|
|
|
